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INTRODUCTION
High-frequency oscillatory ventilation (HFOV) is now widely 
used as an artificial ventilator that actively performs 180−900 
breaths per minute with a very small tidal volume (VT).1 It is 
used as rescue therapy for severe respiratory failure in prema-
ture infants, and it contributes to reduce the incidence of bron-
chopulmonary dysplasia.2-5
The settings of the HFOV are based on the fraction of inspired 
oxygen (FiO2) for oxygen (O2) saturation, mean arterial pres-
sure (MAP), which is about 2−4 cm H2O higher than the aver-
age airway pressure of conventional mechanical ventilation, 
amplitude of chest vibration to the umbilicus, and frequency 
of approximately 10−15 Hz.6-8 On the basis of the carbon diox-
ide diffusion coefficient (DCO2) and VT, physicians can con-
firm the effect of oxygenation and ventilation.9
In particular, the DCO2 indicates the effectiveness of CO2 re-
moval. It has various values depending on the size of the lung, 
and it is calculated as the product of the squared VT and the fre-
quency.10,11 Setting parameters in HFOV, according to the lung 
pathology, is left to the discretion of the physician, and appro-
priate DCO2 and VT values have not yet been established. When 
the DCO2 is below 40 mL2/s, it has been reported that the prob-
ability of a pCO2 below 50 mm Hg is estimated to be 49%, and 
the appropriate DCO2 value for extremely low-birth-weight 
(ELBW) infants has been reported as 18.5 mm Hg.12 VT refers 
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Purpose: Removal of CO2 is much efficient during high-frequency oscillatory ventilation (HFOV) for preterm infants. However, 
an optimal carbon dioxide diffusion coefficient (DCO2) and tidal volume (VT) have not yet been established due to much indi-
vidual variance. This study aimed to analyze DCO2 values, VT, and minute volume in very-low-birth-weight (VLBW) infants using 
HFOV and correlates with plasma CO2 (pCO2).
Materials and Methods: Daily respiratory mechanics and ventilator settings from twenty VLBW infants and their two hundred 
seventeen results of blood gas analysis were collected. Patients were treated with the Dräger Babylog VN500 ventilator (Dräger-
werk Ag & Co.) in HFOV mode. The normocapnia was indicated as pCO2 ranging from 45 mm Hg to 55 mm Hg. 
Results: The measured VT was 1.7 mL/kg, minute volume was 0.7 mL/kg, and DCO2 was 43.5 mL2/s. Mean results of the blood 
gas test were as follows: pH, 7.31; pCO2, 52.6 mm Hg; and SpO2, 90.5%. In normocapnic state, the mean VT was significantly high-
er than in hypercapnic state (2.1±0.5 mL/kg vs. 1.6±0.3 mL/kg), and the mean DCO2 showed significant difference (68.4±32.7 
mL2/s vs. 32.4±15.7 mL2/s). The DCO2 was significantly correlated with the pCO2 (p=0.024). In the receiver operating curve analysis, 
the estimated optimal cut-off point to predict the remaining normocapnic status was a VT of 1.75 mL/kg (sensitivity 73%, speci-
ficity 80%). 
Conclusion: In VLBW infants treated with HFOV, VT of 1.75 mL/kg is recommended for maintaining proper ventilation.
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to VT averaged over several cycles, and it is generally recom-
mended to set it to 1.5−2 mL/kg.12 This, however, depends on 
the lung mechanics and ventilator mechanics, since the vol-
ume of the lung increases as the frequency of ventilation de-
creases. For greater lung compliance, an ideal VT should be 
maintained in order to prevent hyperinflation.13 One study re-
ported that the set VT values varied between from 1.46 mL/kg 
for ELBW infants and 1.57 mL/kg for infants weighing 1000− 
2000 g.14 In another preterm study of infants <32 weeks of ges-
tation, the targeted VT ranged from 1.5 mL/kg to 2.5 mL/kg, 
and only 51% of infants had normocapnia.12 
In the present study, we aim to analyze the respiratory me-
chanics, especially DCO2 values, VT, and minute volume and 
correlate them with plasma CO2 (pCO2) in very-low-birth-weight 
(VLBW) infants using HFOV.  
MATERIALS AND METHODS
Patients
This retrospective study comprised 20 VLBW infants, who re-
ceived HFOV without volume guarantee for treatment of re-
spiratory failure. These patients had all been admitted to the 
neonatal intensive care unit of Gangnam Severance Hospital 
between March 2015 and February 2016. Their two hundred 
seventeen results of blood gas analysis were collected. Ethical 
approval was obtained from the ethics committees of Gang-
nam Severance Hospital and informed consent was waived 
(IRB approval number; 3-2017-0120).
Ventilator
HFOV was delivered using a Dräger Babylog VN500 ventilator 
(Drägerwerk Ag & Co., Lübeck, Germany) with a Venturi system. 
It generates active inspiration and active expiration to induce a 
sinusoidal pressure signal around a set mean airway pressure. 
The Dräger Babylog VN500 ventilator uses a double hot-wire 
anemometer, which has been demonstrated to be a very accurate 
way of measuring frequency of expired VT during HFOV, as there 
is greater linearity of response across a range of frequencies.15
Ventilation strategies
HFOV was set as a mean airway pressure of 1 to 2 cm H2O high-
er than that received during conventional mechanical ventila-
tion and the same inspired oxygen fraction. In chest radio-
graph, the lung volume was evaluated with the right diaphragm 
at the level of the ninth rib. A frequency of 10−12 Hz and an os-
cillatory inspiratory/expiratory ratio of 1:1 were used in all in-
fants. An amplitude set above the mean airway pressure value 
was increased until visible chest wall movement up to the um-
bilicus level was noted. 
If the PCO2 value was outside the target range, the ampli-
tude was adjusted up or down in increments of 10−20% as nec-
essary in the HFOV alone period. Capillary blood gases were 
measured 1 hour after applying HFOV and then at 6−8-hour in-
tervals or more often as needed using a blood gas analyser. The 
FiO2 was given as needed to achieve a peripheral capillary ox-
ygen saturation (SpO2) between 90% and 95% by pulse oximetry.
Data acquisition and analysis
During ventilation, a hot-wire anemometer was placed on the 
airway opening to continuously measure the flow and VT dur-
ing HFOV. The VT, Paw, minute volume, and DCO2 were calcu-
lated as VT2×frequency (mL2/s) by the ventilator (Dräger Baby-
log VN500 2.n software, Dräger) and recorded at 1 minute. Data 
from the ventilator were exported through a standard USB con-
nection.
The following data were also collected from patients includ-
ed in the study: demographic characteristics, perinatal pathol-
ogy and treatment, clinical course, initial and final ventilator set-
tings, vital signs, and capillary blood gas analysis. When analysing 
the blood gas analysis, pCO2 values between 45 and 55 mm Hg 
were considered normocapnia.
Statistical analysis
Data were compared using the t-test and chi-square test. All 
statistical analyses were performed using SPSS for Windows, 
version 19.0 (IBM Corp., Armonk, NY, USA). A p-value <0.05 
was considered statistically significant.
RESULTS
The study population consisted of 20 VLBW infants with a me-
dian gestational age of 28.3 weeks and median birth weight of 
1050 g. The 1-minute Apgar score was 2.5, and the 5-minute Ap-
gar score was 5.4 points. Age at the start of HFOV was 5.3 days, 
and the duration of HFOV was 10.3 days. Surfactant replace-
ment therapy was administered to all the infants, and five in-
fants received multiple therapy. No patients with congenital 
anomalies affecting the cardiac, respiratory or central nervous 
system were found. Eleven infants had a maternal history of 
chorioamnionitis, and 15 received steroid treatment (Table 1).
The ventilator parameters were set as follows: inspiratory-to-
expiratory (I/E) time ratio, 1:1; frequency, 10.5 Hz; amplitude, 
23.6 cm H2O; and MAP, 11.7 cm H2O. The measured VT was 
1.7 mL/kg, minute volume was 0.7 mL/kg, and DCO2 was 43.5 
mL2/s. Median results of the blood gas test were as follows: 
pH, 7.31; pCO2, 52.6 mm Hg; and SpO2, 90.5% (Table 2).
In a comparison of the normocapnia and hypercapnia 
groups, the VT, minute volume, and DCO2 were statistically sig-
nificantly different. The mean VT of the normocapnia group 
was 2.1 mL/kg, minute volume was 0.9 mL/kg, and DCO2 was 
68.4 mL2/s (Table 3). The relationship between pCO2 and 
DCO2 was negative. The correlation between the VT and pCO2 
was also negative, shown in Fig. 1. When we divided infants into 
4 groups according to the DCO2 value, the percentage of infants 
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Table 1. Patient Characteristics
Characteristics (n=20) Median (range)
Gestation age (wk)     28.3 (23.8–33.1)
Birth weight (g)    1050 (620–1500)
Male:Female 1:1.57
Apgar score-1   2.5 (1.0–5.0)
Apgar score-5   5.4 (3.0–8.0)
Hospital day (d) 68.6 (31–133)
Age at the start of HFOV (days)     5.3 (2.0–21.0)
Duration of HFOV (days)   10.3 (4.0–30.0)
Number of surfactant administration, n (%)
1 15 (75)
2   3 (15)
3   2 (5)
Chorioamnionitis, n (%) 11 (55)
Antenatal steroid treatment, n (%) 15 (75)
HFOV, high-frequency oscillatory ventilation. 
Table 2. Ventilator Parameters and Results of Blood Gas Analysis
Parameters and gas analysis (n=217) Median (range)
I:E 1:1
Frequency (Hz) 10.5 (9.0–12.0)
Amplitude (cm H2O) 23.6 (15.0–30.0)
MAP (cm H2O) 11.7 (7.0–15.0)
FiO2 0.46 (0.30–0.80)
Tidal volume (mL/kg)   1.7 (1.2–2.3)
Minute volume (mL/kg)   0.7 (0.2–1.2)
DCO2 (mL2/sec) 43.5 (20.5–88.3)
pH 7.31 (7.08–7.51)
pCO2 (mm Hg) 52.6 (32.8–88.6)
SpO2 (%) 90.5 (82.0–100.0)
HFOV, high-frequency oscillatory ventilation; I:E, inspiratory-to-expiratory 
time ratio; MAP, mean arterial pressure; FiO2, fraction of inspired oxygen; 
DCO2, carbon dioxide diffusion coefficient; pCO2, plasma CO2; SpO2, peripher-
al capillary oxygen saturation.
Table 3. Comparisons of Parameters between Normocapnia and Hypercapnia Group
Parameters Normocapnia (n=105) Hypercapnia (n=112) p value
Frequency, mean (±SD, Hz) 11.2 (±1.2)  10.9 (±1.1)   0.035
Amplitude, mean (±SD, cm H2O) 24.6 (±6.2)   23.7 (±4.2) <0.001
MAP, mean (±SD, cm H2O) 11.9 (±5.3)  12.1 (±4.8) <0.018
FiO2, mean (±SD)   0.32 (±0.16)    0.49 (±0.14) <0.001
Tidal volume, mean (±SD, mL/kg)   2.1 (±0.5)    1.6 (±0.3) <0.001
Minute volume, mean (±SD, mL/kg)   0.9 (±0.2)    0.6 (±0.3) <0.001
DCO2, mean (±SD, mL2/sec)   68.4 (±32.7)    32.4 (±15.7) <0.001
SpO2, mean (±SD, %) 91.5 (±5.9)  90.1 (±4.9)   0.542
MAP, mean arterial pressure; FiO2, fraction of inspired oxygen; DCO2, carbon dioxide diffusion coefficient; SpO2, peripheral capillary oxygen saturation; SD, stan-
dard deviation.
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Fig. 1. Correlation analysis between DCO2 and pCO2 and between VT and pCO2. DCO2 values showed negative correlation with pCO2. VT showed neg-
ative correlation with pCO2. DCO2, carbon dioxide diffusion coefficient; pCO2, plasma CO2; VT, tidal volume.
with normocapnia corresponding to a pCO2 <55 mm Hg was 
83% for a DCO2 40−60 mL2/s in each DCO2 group (Table 4). 
According to the receiver operating characteristic curves, the 
area under the curve for normocapnic status was 0.833 (p= 
0.041). The estimated optimal cut-off points to predict the re-
maining normocapnic status was a VT of 1.75 mL/kg (sensi-
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tivity 73%, specificity 80%) (Fig. 2).
DISCUSSION
HFOV is widely used as a treatment of choice and rescue ther-
apy for respiratory failure in preterm infants. The use of elec-
tive HFOV can result in a reduction in the risk of chronic lung 
disease.7 However, the respiratory mechanics in infants venti-
lated with the Dräger Babylog VN500 ventilator or other HFOV 
devices has much individual variance, thus few studies have 
reported appropriate data. The present study is meaningful, 
as it is the first one to assess the respiratory mechanics using 
the Dräger Babylog VN500 ventilator and to analyse the venti-
lation status of Korean VLBW infants.
Severe hypercapnia and hypocapnia may cause neonatal 
brain injury. These conditions can induce changes in the ce-
rebral blood volume.16 The association between hypocapnia 
and periventricular leukomalacia in preterm infants is well 
documented.17,18  Severe hypercapnia is associated with organ 
dysfunction, including barotrauma, renal dysfunction, cardio-
vascular dysfunction, and an increased motality risk in the in-
tensive care unit (odds ratio 1.93).19  Furthermore, a high pCO2 
value has been shown to be a risk factor for severe intraven-
tricular haemorrhage.20 Therefore, it is essential to maintain 
normocapnia in patients under ventilator care. However, fre-
quent sampling to check the pCO2 level is limited in VLBW in-
fants.
HFOV is effective for ventilation control compared to con-
ventional mechanical ventilation.21 Targeting the ideal DCO2 
may induce a more stable PCO2 level, which has the potential 
to reduce both hypercarbia and hypocarbia. However, the 
DCO2 has various values depending on the size of the lung and 
underlying conditions, and the absolute target value has not 
yet been confirmed.22 In a previous study, the mean values of 
DCO2 according to body weight were reported according to 
the weight ranges in extremely low birth weight infants, in 
those weighing between 1000 g and 2000 g, and in those weigh-
ing over 2000 g.14 In the present study, we confirmed that 
DCO2 and pCO2 values were more useful to maintain normo-
capnia with proper ventilation than DCO2 values of above 40 
mL2/s in VLBW infants. In a neonatal animal model, no signifi-
cant changes on CO2 elimination are observed during HFOV 
with I/E ratios of 1:1 and 1:2 both.23 
Considering the correlation between lung pressure and 
lung inflation, maintenance of adequate VT between under-in-
flation and over-inflation is essential to prevent barotrauma.24,25 
It has been reported that the VT improved CO2 elimination, 
and it had a greater effect than the frequency of ventilation.23,26 
HFOV is useful for maintaining the VT within the target range 
of normocapnia, and it is associated with a low incidence of hy-
pocapnia and hypercapnia compared to conventional ventila-
tion. The most important consideration is that the optimal ini-
tial value of VT is not yet clearly known. VT decreases with 
increasing frequency, and it increases with increasing compli-
ance and the tracheal tube diameter. One study used a target VT 
of 2 mL/kg, as the expected dead space was thought to be ap-
proximately 2.2 mL/kg in healthy, awake neonates.27 
To date, few studies have evaluated the optimal VT target in 
neonates during HFOV, because these values vary with gesta-
tional or postnatal age and underlying disease. In a study of in-
fants who had been ventilated by HFOV at all time during their 
hospital days, the median gestation age was 27.2 weeks (range, 
23.3−41.0 weeks) and respiratory distress syndrome (RDS) was 
most commonly diagnosed (56%), followed by lung hypoplasia 
(14%). The median delivered normocapnic VT during HFOV 
was 1.67 mL/kg, and the median suggested hypocapnic and 
hypercapnic VTs were 1.94 mL/kg and 1.54 mL/kg, respective-
ly.28 Other studies demonstrated that the median delivered 
normocapnic VT during HFOV was 1.74 mL/kg, median hypo-
capnic VT was 1.97 mL/kg, and median hypercapnic VT was 
1.54 mL/kg in preterm infants during the initial phase of RDS.12 
A previous study showed that the adequate VT was 1.46 mL/kg 
for ELBW infants, 1.57 mL/kg for infants weighing 1000−2000 g, 
and 2.27 mL/kg for infants weighing over 2000 g. In the pres-
ent study, the mean VT for normocapnia was 2.1 mL/kg, and 
the minute volume was 0.9 mL/kg in VLBW infants.14
Another study showed that an increase in VT from 2 to 3 mL/kg 
Table 4. Incidence of Normocapnia According to the DCO2 Value Ranges
DCO2 (mL2/sec) pCO2 (below 55 mm Hg)
<40 35% (19/55)
40−60 83% (81/98)
60−80 86% (38/44)
>80 91% (21/23)
DCO2, carbon dioxide diffusion coefficient; pCO2, plasma CO2.
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Fig. 2. ROC curve analysis. On the ROC curve analysis, setting of the tid-
al volume at 1.75 mL/kg was able to maintain normocapnia with a sensi-
tivity of 73%, specificity of 80%, and an AUC of 0.833. ROC, receiver op-
erating characteristic curves; AUC, area under the curve.
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resulted in a decrease in the pCO2 level from 60±11 mm Hg to 
51±8 mm Hg with concomitant increases in the amplitude and 
DCO2 in a newborn piglet model, and the DCO2 value was 68.4 
mL2/s.29 In this study, the correlation between the VT and pCO2 
was also significantly negative.
The present study has a limitation in the exact analysis of nor-
mocapnia and hypercapnia because of the small number of 
patients and failure to distinguish between arterial, venous, and 
capillary blood. The individual variances about lung patholo-
gy and underlying condition were not adjusted. Because fixed 
frequency was not used though 10−12 Hz small ranges, the ef-
fect of decreased VT with increasing frequency was ignored. 
Actually, when the frequency changes from 10 Hz to 12 Hz, the 
dependency of oscillatory volume on frequency changes from 
6.6 mL to 4.6 mL in 10 mbar MAP.30 Because of the small num-
ber of patients, we couldn’t divide the result of the blood test 
by frequency of the HFOV. We also examined only short-term 
physiological and respiratory variables; thus, the potential long-
term benefits are only speculative. 
In conclusion, it is advisable to maintain a normocapnia 
state with a VT of 1.75 mL/kg in VLBW infants and a DCO2 val-
ue of ≥40 mL2/s. Further studies are needed to establish this 
topic further.
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